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Brown adipose tissue (BAT) is known to secrete regulatory factors in response to thermo-
genic stimuli. Components of the BAT secretome may exert local effects that contribute to
BAT recruitment and activation. Here, we found that a thermogenic stimulus leads to
enhanced secretion of kininogen (Kng) by BAT, owing to induction of kininogen 2 (Kng2)
gene expression. Noradrenergic, cAMP-mediated signals induce KNG2 expression and
release in brown adipocytes. Conversely, the expression of kinin receptors, that are activated
by the Kng products bradykinin and [Des-Arg9]-bradykinin, are repressed by thermogenic
activation of BAT in vivo and of brown adipocytes in vitro. Loss-of-function models for Kng
(the circulating-Kng-deficient BN/Ka rat) and bradykinin (pharmacological inhibition of kinin
receptors, kinin receptor-null mice) signaling were coincident in showing abnormal over-
activation of BAT. Studies in vitro indicated that Kng and bradykinin exert repressive effects
on brown adipocyte thermogenic activity by interfering the PKA/p38 MAPK pathway of
control of Ucp1 gene transcription, whereas impaired kinin receptor expression enhances it.
Our findings identify the kallikrein–kinin system as a relevant component of BAT thermogenic
regulation that provides auto-regulatory inhibitory signaling to BAT.
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Obesity and type II diabetes are reaching pandemic pro-portions worldwide. Understanding the mechanismsunderlying disturbed glucose and lipid metabolism is
thus of great interest for efforts to identify new therapeutic targets
for the treatment of these disorders.
Experimental studies have shown that impaired brown adipose
tissue (BAT) activity is associated with obesity and insulin
resistance. Conversely, highly active BAT is associated with a
healthy metabolic phenotype that is generally attributed to the
capacity of BAT to dissipate metabolic energy as heat through
uncoupling protein 1 (UCP1)-mediated uncoupled mitochondrial
oxidation1. In rodents, in addition to anatomically defined BAT
sites that arise during ontogeny, brown adipocytes of distinct
cellular origin, termed beige or brite, appear in white adipose
tissue (WAT) depots after persistent thermogenic activation in
the organism, a phenomenon referred to as browning or beiging
of WAT2. This type of brown adipocyte appears to be the one that
predominates in adult humans3. Genetic studies in rodents
attribute an especially relevant role of the beiging process to
protection against obesity4.
Recent findings suggest that the biological function of BAT
might not be restricted to the unique function of energy con-
sumption, and reports based on experimental BAT transplanta-
tion point to a role for this tissue as a source of endocrine
signaling and release the so-called brown adipokines or
batokines5,6. Given the very distinct functions of WAT and BAT
in energy metabolism, it would be reasonable to expect that the
profile of batokines released by BAT would be different from
adipokines released by WAT. Our laboratory recently conducted
a study aimed at discovering new potential molecules secreted by
BAT, based on microarray and RNAseq data in BAT combined
with bioinformatic prediction of secretability. Two candidate
genes—Cxcl14, a recently characterized chemokine released by
BAT7, and Kng (kininogen)—were identified. The
kallikrein–kinin system, of which Kng is a part, is a complex
hormonal signaling system with reported involvement in
inflammation, blood pressure control, coagulation, and pain8.
Because of alternative splicing, Kng encodes two different pro-
teins: a high-molecular-weight Kng (HMWK) and a low-
molecular-weight Kng (LMWK)9. In the human genome, only
one gene (KNG1) has been described to date, whereas the mouse
genome possesses a second gene, Kng2, in addition to Kng110.
These two murine genes have a sequence identity of ~89%. The
liver is considered the main site of KNG proteins production.
Once HMWK is produced and released into the bloodstream, it is
targeted by plasmatic kallikrein protease, yielding the active
peptide bradykinin. In contrast, LMWK is cleaved by tissue kal-
likrein, releasing the active kallidin into the blood11. Bradykinin
and kallidin are considered to act as vasodilators and target many
cell types by activating the kinin B2 (B2) receptor, which is
constitutively expressed in cells. Bradykinin and kallidin are
ultimately cleaved again to produce the peptides, [Des-Arg9]-
bradykinin/kallidin; these peptides act on the kinin B1 (B1)
receptor, whose expression is induced by distinct stimuli,
including inflammation8. A summary of these pathways is shown
in Fig. 1a.
Very few reports to date have indicated a role for the kinin
system in systemic metabolic regulation and adipose tissue biol-
ogy. One group proposed that a B1 receptor deficiency leads to
leptin hypersensitivity and resistance to obesity12. A subsequent
study from the same group suggested that kinin B1 and B2
receptor deficiencies improve glucose tolerance and have a pro-
tective role against high-fat-diet-induced obesity in mice13. To
date, however, no studies describing a role for Kng in BAT
functions or secretory properties have been reported. Here, we
identify KNG2 as a component of thermogenic stimulus-induced
BAT adaptations and describe a key role for the kallikrein–kinin
system in adipose tissue plasticity in response to thermogenic
challenges.
Results
Kng2 is the preferential Kng gene expressed in BAT. To identify
new brown adipokines, we performed a bioinformatic analysis of
transcripts encoding potentially secreted proteins that are dif-
ferentially expressed in mouse BAT-versus-WAT and cold-
stimulated BAT versus BAT from mice at a thermoneutral tem-
perature. This analysis identified two candidate genes, Cxcl14,
further confirmed as a functional brown adipokine that targets
immune cells7, and Kng1. The identification of Kng1 as a gene
that is preferentially expressed in interscapular BAT (iBAT)
relative to white fat depots and induced in iBAT in response to
thermogenic challenge of mice is consistent with a previous
microarray-based report14. However, attempts to validate reg-
ulation of the Kng1 transcript in iBAT in response to cold by
specifically measuring Kng1 transcript levels yielded results
inconsistent with omics-based data. This prompted us to explore
whether the presence of the closely related, highly homologous,
gene Kng2 might have influenced the initial omics-based identi-
fication of Kng1 as a regulated gene.
Using primers designed to allow specific measurement
(see Supplementary Methods) of Kng1 and Kng2 transcripts
abundance, in both cases distinguishing between HMWK- and
LMWK-encoding transcripts, we found that Kng1 transcripts
were indeed undetectable in iBAT from Swiss mice and showed
minor, but detectable, expression in iWAT (Fig. 1b, left). This
contrasted with the liver, where Kng1 was highly expressed.
However, Kng2 transcripts, especially LMWK, were markedly
expressed in iBAT. In fact, the relative abundance of the LMWK
Kng2 form in iBAT was in the range of that in the liver, the main
Kng-producing tissue, whereas the level of the HMWK Kng2
transcript in iBAT was approximately one-third of that in liver
(Fig. 1b, left).
BAT activation and WAT browning increase KNG2 expres-
sion. We found that Kng1 transcript expression remained
undetectable in iBAT of cold-exposed Swiss mice, whereas cold
dramatically induced the expression of both HMWK and LMWK
Kng2 transcripts (Fig. 1b, right). Although expression of the
HMWK Kng2 transcript was not induced by cold exposure in
iWAT, expression of the LMWK Kng2 transcript increased
(Fig. 1b, right). These effects occurred specifically in adipose
tissues, as there was no evidence for a cold-induced increase in
Kng transcript abundance in the liver (Fig. 1b, right), muscle,
heart, or intestine (Supplementary Fig. 1). The levels of KNG2
protein in iBAT and iWAT from cold-exposed mice were sig-
nificantly upregulated, consistently with Kng2 transcript levels
(Fig. 1c). These data establish that Kng2 is the gene that is actually
regulated by a thermogenic stimulus in iBAT. The original
identification of Kng1 as a regulated transcript in omics-based
data was thus likely attributable to the very high sequence simi-
larity between the two genes and an inability of hybridization-
based quantification in microarray assays to discriminate between
them. Notably, a study by Fitzgibbons et al. previously identified
Kng2 as being preferentially expressed in iBAT15.
We next investigated the effect of cold exposure on plasma
levels of circulating Kng (HMWK type) and found a significant
cold-induced increase in KNG2 levels, but not KNG1 levels
(Fig. 1d). This confirms the preferential sensitivity of KNG2
protein synthesis to cold challenge as well as the systemic impact
of thermogenic activation of BAT on the Kng system.
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Fig. 1 Differential expression of Kng genes in tissues. a Representation of the Kng system. LMWK, low molecular weight kininogen; HMWK, high
molecular weight kininogen; Kl, kallidin; Bk, bradykinin; Dkl, [Des-Arg9]-kallidin; Dbk, [Des-Arg9]-bradykinin; B2, kinin B2 receptor; B1, kinin B1 receptor. b
mRNA expression of the different Kngs in iBAT, iWAT and liver of 2 months old Swiss mice (n= 5 animals; except for iWAT Kng2 HMWK and LMWK left
graph where n= 4). mRNA expression of Kngs in fat depots and liver of 2 months old Swiss mice exposed to cold or control room temperature for 1 week
(n= 5 animals). c KNG2 protein expression in iBAT and iWAT of mice exposed to RT or 4 °C (n= 3 animals). d KNG1 and -2 protein expression in plasma
of WT mice exposed to cold for 1 week (n= 4 animals; except for KNG1 4 °C where n= 3). ND, not detectable; NS, not significant. Data are presented as
means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus corresponding controls. P-values determined by two ways ANOVA with Tukey’s post
hoc test (b left) and two-tailed unpaired Student’s t-test (b right, c, d). Source data are provided as a Source data file.
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Noradrenergic stimuli induce Kng2 in brown adipocytes. We
then investigated whether thermogenically induced expression
and release of KNG2 in BAT represents a cell-autonomous
response of brown adipocytes to classic adrenergically mediated
thermogenic stimulation. First, we found that HMWK Kng2
mRNA was induced during brown adipocyte differentiation
in vitro (mostly at early stages), whereas LMWK Kng2 mRNA
expression was dramatically increased in association with differ-
entiation (Fig. 2a). We found that both norepinephrine and the
β3-specific agonist CL316243 significantly increased HMWK
Kng2 mRNA levels (Fig. 2b). This resulted in an increase in












































































































































































D4 D6 D8 D10
CL
CTL cAMP NE CLCTL cAMP NE CL
CTL cAMP NE CL CTL cAMP NE CL
CTL cAMP NE
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16009-x
4 NATURE COMMUNICATIONS |         (2020) 11:2132 | https://doi.org/10.1038/s41467-020-16009-x | www.nature.com/naturecommunications
norepinephrine, CL316243 and cAMP treatments, all of which
elicited enhanced thermogenic activation, as shown by the
induction of Ucp1 transcript levels (Fig. 2b). In primary adipocyte
cultures from iWAT precursors, induction of beiging by rosigli-
tazone (see massive induction of Ucp1 gene transcript levels) also
resulted in a tendency of HMWK Kng2 transcripts to increase
and caused a significant induction of LMWK Kng2 transcript
levels (Fig. 2c, top). Moreover, in differentiated beige adipocytes,
CL316243 and cAMP increased KNG2 protein levels (Fig. 2c,
bottom).
Rats devoid of circulating Kng have over-activated BAT. As a
first approach for determining the role of Kng in vivo, we ana-
lyzed the phenotype of Brown Norway Katholiek (BN/Ka) rats in
relation to systemic metabolism, thermoregulation, and BAT
function. BN/Ka rats harbor a spontaneous point mutation of
alanine to threonine at residue 163 in the KNG2 protein that
leads to a defect in secretion of HMWK and a consequent defi-
ciency of plasma Kng16,17. Control Brown Norway (BN) rats
showed enhanced Kng2 expression in iBAT in response to short-
and long-term cold, similar to mice (Fig. 3a). As expected, we
found that HMW-KNG2 protein was almost undetectable in the
blood of BN/Ka rats (Fig. 3b). BN/Ka rats showed no gross
alterations in body weight or food intake. They also showed no
changes in insulin or pro-inflammatory cytokines, as previously
reported18; the only change in metabolic parameters detected was
a mild reduction in glycemia (Supplementary Table 1). Liver and
WAT mass (estimated from the epididymal depot) were unaltered
in BN/Ka rats, whereas the iBAT depot was significantly larger
(Supplementary Table 1). A histological examination revealed
that this enlargement was not attributable to fat accumulation
(Fig. 3c). Both relative UCP1 protein levels and absolute UCP1
levels per iBAT (indicative of thermogenic potential) were sig-
nificantly increased in iBAT from BN/Ka rats (Fig. 3d). That
increased recruitment of iBAT in BN/Ka rats had functional
consequences and is demonstrated by measurements of local
temperature at the iBAT skin surface region, which was sig-
nificantly increased (Fig. 3e). In summary, the deficiency in
Fig. 2 Kng2 regulation in murine primary brown and beige adipocytes. a mRNA expression of the two Kng2 variants during primary brown adipocyte
differentiation (n= 3 independent cell culture experiments for D4 and D8 and n= 4 for D6 and D10). D4–8, day 4–8 of differentiation; D10, day 10, fully
differentiated adipocytes. b Kng2 mRNA (n= 4 independent cell culture experiments) and protein expression (n= 3 independent cell culture experiments)
in primary brown adipocytes after stimulation with β-adrenergic activators. Ucp1 is shown as a positive control for effects of drugs on cells. c Kng2 mRNA
(n= 3 independent cell culture experiments for Kng2 HMWK and LMWK; n= 5 independent cell culture experiments for Ucp1 −Rosi; n= 6 independent
cell culture experiments for Ucp1 +Rosi) and protein expression (n= 3 independent cell culture experiments) in primary inguinal white adipocytes after
stimulation with rosiglitazone or β-adrenergic activators. Ucp1 is shown as a positive control for the browning effect of rosiglitazone. Data are presented as
means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus corresponding controls. P-values determined by one way ANOVA with Tukey’s post


















































































































































Fig. 3 Regulation of Kng2 expression and BAT activity in BN/Ka rats. a mRNA expression of K-kininogen (Kng2) in iBAT from 12 weeks old BN and BN/
Ka rats at thermoneutrality (27 °C) and after 24 h or 22 days exposure to cold (4 °C) (n= 4 animals). b HMW-KNG2 protein expression in plasma and
quantification in BN and BN/Ka rats under thermoneutral conditions (n= 3 animals). c Optical microscopy of H&E-stained iBAT from BN and BN/Ka rats
under thermoneutral conditions (n= 4 animals). d UCP1 protein expression and quantification of UCP1 protein levels, expressed per tissue and total protein
(below), in iBAT from BN and BN/Ka rats under thermoneutral conditions (n= 4 animals). e Representative infrared thermographies (left) and
quantification of iBAT temperature (right) in BN and BN/Ka rats under thermoneutral conditions (n= 4 animals). ND, not detectable. Data are presented
as means ± s.e.m. (bars). *P < 0.05 and ***P < 0.001 versus BN; #P < 0.05 versus thermoneutrality. P-values determined by two-tailed unpaired Student’s t-
test (for genotypes) and two ways ANOVA with Tukey’s post hoc test (for temperature) (a) and two-tailed unpaired Student’s t-test (b, d, e). Source data
are provided as a Source data file.
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KNG2 protein in BN/Ka rats was associated to some extent with
iBAT thermogenic activation. Notably, however, rats (but not
mice or humans) harbor two additional genes encoding Kng-
related proteins, T-Kng-I and T-Kng-II, which encode proteins
with functions that are similar to but not completely overlapping
with those of HMW-KNG2 and LMW-KNG2, encoded by the rat
Kng2 gene19. We found that the deficiency in KNG2 secretion in
BN/Ka rats was accompanied by a dramatic induction of T-Kng-I
and T-Kng-II transcripts in iBAT (Supplementary Fig. 2). Thus,
the possibility that T-Kng–mediated compensatory processes tone
down the impact of a KNG2 deficiency in the BN/Ka rat cannot
be ruled out. In any case, results obtained using the BN/Ka model
suggest that the most sensitive target of a KNG2 deficiency is
BAT itself.
Effects of thermogenic challenges on B1 and B2 expression.
Considering that Kng gene expression results in the release of
HMWK and the bioactive peptides kallidin and bradykinin,
which target cells through the kinin receptors B1 and B2, we
analyzed the expression of these receptors in mouse iBAT as part
of an exploration of putative local (autocrine/paracrine) effects of
thermogenically induced Kng2 gene expression.
We found that expression of B1 and B2 genes was inversely
regulated in accordance with the extent of thermogenic challenge
in mice (Fig. 4a), such that cold exposure (4 °C, 1 week) caused a
general trend to decrease B1 and B2 expression in iBAT, and
exposure to 30 °C for 1 week, which suppresses thermogenically
induced BAT activity, resulted in a dramatic induction of B1 and
B2 gene expression. This response was opposite that of Ucp1
mRNA, used as a marker for the extent of thermogenic induction.
A similar behavior was found in iWAT, in which cold-induced
promotion of browning tended to decrease B1 and B2 mRNA
expression, whereas suppression of browning by exposure to 30 °
C (which essentially abrogated Ucp1 mRNA expression) resulted
in strong induction of B1 and B2 transcripts (Fig. 4a). We also
found that expression of B1 and B2 receptor genes was
significantly downregulated in association with differentiation of
brown adipocytes. B1 and B2 transcripts were reciprocally
regulated relative to those of Ucp1 throughout the time-course
of brown adipocyte differentiation (Fig. 4b).
The transcript levels of other components of the kinin system,
such as plasma kallikrein b1 (Klkb1), kininase I (Klk1) and
angiotensin-converting enzyme (Ace) were not affected significantly
by environmental thermal challenges (Supplementary Fig. 3).
Pharmacologic inhibition of B1/B2 receptors overactivates
BAT. The fact that thermogenic-mediated induction of Kng2 is
accompanied by repressive effects on B1 and B2 receptor
expression raises the question of what effect inhibiting B1 and B2
receptor activity has on the responsiveness to a thermogenic
stimulus. To address this question, we implanted mini-pumps
containing a cocktail of B1 and B2 receptors antagonists in the
subcutaneous dorsal area of mice, just over the interscapular BAT
depot, and exposed mice to 4 °C for 1 week. Neither systemic
metabolic and circulating profiles (Supplementary Table 2), nor
iWAT parameters (Supplementary Fig. 4) were altered by this
treatment. However, we found that, in mice treated with
antagonists, the size of iBAT and the diameters of cells were
smaller (Fig. 5a), the percentage of protein content in the tissue
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Fig. 4 B1 and B2 receptor expression. a B1 and B2 receptor mRNA expression in iBAT and iWAT of mice exposed to cold or thermoneutrality for 1 week (n
= 5 animals except for iBAT Ucp1 30 °C where n= 3 and iWAT 30 °C all genes where n= 4). Ucp1 is shown as a control for the efficiency of thermogenic
challenges. b mRNA expression of B1 and B2 receptors during differentiation (D4–8) and in fully differentiated brown adipocytes (D10) (n= 3 independent
cell culture experiments for D4 and D8 and n= 4 for D6 and D10 for B1 and B2 genes; n= 3 for D4 and D8 and n= 6 for D6 and n= 5 for D10 for Ucp1
gene). Ucp1 is shown as a positive control for differentiation. Data are presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus
corresponding controls; one way ANOVA with Tukey’s post hoc test. Source data are provided as a Source data file.
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indicating that the reduction in the size of iBAT was attributable
to a loss of fat and not protein (Fig. 5b). UCP1 protein levels in
iBAT were increased in animals treated with the antagonist
cocktail (Fig. 5c). Taken together, these data indicate that acti-
vation of BAT by cold exposure was more intense in antagonist-
treated mice.
The above data suggest that our B1/B2-antagonist experimental
setting may have exerted mostly local effects upon iBAT. To test
this, we performed an additional experiment in which mini-
pumps delivering B1/B2-antagonists were implanted locally
adjacent to an iWAT depot site, and subsequently exposed mice




















































































































































Fig. 5 Effects of local pharmacological inhibition of B1/B2 receptors at iBAT and iWAT. a H&E-stained iBAT histological sections and quantification (at
least 3 different pictures) of cell size in 2 months old WT C57BL/6J mice exposed to 4 °C for 1 week and then implanted in the back with mini-pumps
delivering either PBS or a cocktail of B1 and B2 antagonists; iBAT weight normalized to tibia length (n= 8 animals for PBS and n= 7 animals for
antagonists). b Quantification of total protein per milligram tissue and in the entire iBAT depot (n= 8 animals for PBS and n= 7 animals for antagonists). c
UCP1 protein expression in iBAT, with quantification (n= 7 animals for PBS and n= 6 animals for antagonists). d H&E-stained iWAT histological sections
and quantification of browning area (at least three different pictures) in 2 months old WT C57BL/6 J mice exposed to 4 °C for 1 week and implanted in the
leg with mini-pumps delivering either PBS or a cocktail of B1 and B2 antagonists; iWAT weight normalized to tibia length (n= 5 animals for PBS and n= 6
animals for antagonists). e Immunofluorescence detection of UCP1 protein in iWAT histological sections, with quantification (at least three different
pictures). Data are presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus corresponding controls; two-tailed unpaired Student’s
t-test. a–c) n= 7; d, e) n= 6. Source data are provided as a Source data file.
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metabolic parameters, such as glycemia and triglyceridemia, or
iBAT parameters, such as iBAT weight or relative and total UCP1
protein levels (Supplementary Fig. 5). However, local infusion of
B1/B2 receptor antagonists dramatically repressed the browning
of iWAT in response to cold, as evidenced by impaired
development of multilocular beige adipocytes (Fig. 5d) and
reduced expression of UCP1 (Fig. 5e). From these observations,
we conclude that local inhibition of B1/B2 receptors has
reciprocal effects on thermogenic activation of BAT and
browning of iWAT.
Effect of B1/B2 receptor KO on response to thermal challenge.
Given the strong regulation of Kng2 gene expression and kinin
receptors in BAT and WAT (determined by thermogenic
requirements and the extent of browning), and the differential
effects of the kininogen system on BAT and iWAT, we undertook
a study of the role of the kallikrein–kinin pathway using mice
with targeted suppression of both B1 and B2 kinin receptor genes
(B1B2R-KO mice)20.
Under basal, room temperature (22 °C) conditions, these mice
showed no gross alterations in growth, body weight or food
intake, and their main biochemical and hormonal parameter
profiles were unaltered (Supplementary Table 3). This is in
agreement with previous data in this mouse model21,22, but in
contrast with a report using an independently-generated B1B2R-
KO mouse that found low leptin and insulin levels13. We
challenged two group of mice with two opposite experimental
settings: (1) 1-week exposure to 4 °C, a thermogenic stimulus
designed to promote WAT browning; or (2) 1-week exposure to a
thermoneutral temperature (30 °C), which induces the whitening
of BAT and WAT. B1B2R-KO mice exposed to 4 °C were not
dramatically intolerant to cold, but general parameters related to
the physiological response to cold environment were remarkably
altered. The increase in food intake, an adaptive response to cold
that occurs in wild type (WT) mice, was significantly reduced in
B1B2R-KO mice, whereas the mass of inguinal, epididymal and
mesenteric WAT was significantly increased in cold-exposed
B1B2R-KO mice relative to WT mice (Supplementary Table 3).
This latter observation reflects the fact that the reduction in WAT
mass in WT mice in response to cold was impaired in B1B2R-KO
mice. These results are consistent with the cold-induced
reduction in circulating leptin levels in WT mice, but not in
B1B2R-KO mice (Supplementary Table 3).
After suppression of the thermogenic stimulus (exposure to 30
°C), food consumption was reduced in WT mice and the mass of
WAT depots was massively increased, consistent with impaired
energy expenditure under these conditions (Supplementary
Table 3). Such adaptations to thermogenic suppression were
severely impaired in B1B2R-KO mice, which showed a general-
ized reduction in their capacity for thermoneutrality induced
increases in WAT mass. This finding is consistent with the
blunted adaptive reduction in food intake and much lower leptin
levels in B1B2R-KO mice relative to WT mice (Supplementary
Table 3).
BAT overactivation is sustained in B1B2R-KO mice. Exposure
of B1B2R-KO mice to cold led to overactivation of BAT relative
to cold-exposed WT mice, as evidenced by increased levels of
UCP1 protein (Fig. 6b). This BAT overactivation was accom-
panied by increased levels of tyrosine hydroxylase (TH) protein,
indicative of enhanced sympathetic innervation (Fig. 6b),
although this was not reflected in massive changes in transcript
levels (Supplementary Table 4). Conversely, B1B2R-KO mice
showed impaired capacity to down-regulate BAT activity when
transferred from 22 °C to thermoneutrality (30 °C), as evidenced
by impaired whitening of BAT based on cell morphology
(Fig. 6a), maintenance of high levels of UCP1 protein (Fig. 6b), a
trend toward higher levels of transcripts for thermogenesis-
related genes (Ucp1, Dio2, C/EBPb, Prdm16, Pgc1a), and reduced
expression of the whitening marker gene Leptin (Supplementary
Table 4). The expression profile of transcripts for genes involved
in fatty acid/glucose metabolism, angiogenesis and local immune
status in iBAT from cold-exposed B1B2R-KO mice was essen-
tially unaltered relative to that in WT mice (Supplementary
Table 4). However, in a thermoneutral setting, marked changes in
the transcript level profile were found in B1B2R-KO relative to
WT mice. Specifically, we observed an overall increase in tran-
script levels for genes involved in fatty acid supply and oxidation
(Lpl, Cd36, Dgat, Lcad, Acox1), and glucose uptake (Glut4)
(Fig. 6c). Moreover, whereas expression of angiogenesis-related
genes was unaltered, transcripts for Tnfa, a pro-inflammatory
gene, were downregulated in iBAT from B1B2R-KO mice
exposed to thermoneutral conditions, and Clec10a mRNA, cor-
responding to alternatively activated macrophages, was recipro-
cally upregulated (Fig. 6c). Collectively, these data confirm that
the adaptive down-regulation of BAT activity in response to
thermoneutrality is impaired in B1B2R-KO mice, and show that
BAT is abnormally over-activated in B1B2R-KO mice, both under
conditions of enhanced and reduced thermogenic requirements.
To directly investigate the functional capacity of BAT to induce
adaptive thermogenesis in B1B2R-KO mice, we determined the
thermal response of iBAT to the β3-adrenergic activator
CL316243. Injection of CL316243 into the interscapular region
caused a more intense induction of heat at iBAT locations in
B1B2R-KO mice than in WT mice (Fig. 7a, b). We also measured
the induction of O2 consumption in response to CL316243 and
found a significant increase in B1B2R-KO mice (Fig. 7c). These
results confirm that B1 and B2 gene invalidation in mice results in
greater thermogenic capacity in association with enhanced
recruitment of BAT.
WAT from B1B2R-KO mice does not adapt to thermal chal-
lenge. We found distinct alterations in WAT from B1B2R-KO
mice compared with those observed in BAT from these mice.
Specifically, B1B2R-KO mice showed impaired WAT browning in
response to cold, as evidenced by the reduced appearance of
multilocular adipocytes in the iWAT depot (Fig. 8a) and reduced
levels of UCP1 and TH proteins (Fig. 8b). In keeping with these
findings, transcript levels of the thermogenesis-related genes,
Ucp1, Dio2 and C/EBPb, were downregulated in iWAT from cold-
exposed B1B2R-KO mice relative to cold-exposed WT mice
(Supplementary Table 5). Interestingly, the inducibility of Kng2
gene expression in response to cold was strongly inhibited in
B1B2R-KO mice (Supplementary Table 5). Moreover, transcript
levels for genes encoding components of fatty acid and glucose
metabolism, as well as those involved in angiogenesis and
immune cell infiltration were largely unaltered in iWAT from
B1B2R-KO mice relative to WT controls (Supplementary
Table 5). On the other hand, suppression of thermogenic
responses by exposure of mice to a thermoneutral temperature of
30 °C tended to be less effective in B1B2R-KO than WT mice, as
evidenced by the smaller adipocytes in WAT from B1B2R-KO
mice relative to those from WT mice. TH protein was also
maintained at higher levels in B1B2R-KO mice relative to WT
mice under thermoneutral conditions (Fig. 8b).
The kallikrein–kinin system inhibits brown/beige adipocytes
thermogenesis. Having established that the thermogenic
recruitment of iBAT and iWAT are altered following experi-
mental manipulation of the kallikrein–kinin system in rodent
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16009-x

















22 °C 4 °C 22 °C 4 °C



































































































































Fig. 6 Effects of temperature challenges on BAT from B1B2R-KO mice. a H&E-stained histological sections (at least 3 different pictures) of iBAT from
3 months old WT and B1B2R-KO exposed to 4 °C or 30 °C for 1 week. b Expression and quantification of UCP1 and TH protein (n= 3 animals except for
UCP1 30 °C where n= 6). c mRNA expression of genes involved in fatty acid and glucose metabolism, angiogenesis, and the immune system (n= 5
animals). Data are presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01 and, ***P < 0.001 versus corresponding controls; two-tailed unpaired Student’s
t-test. Source data are provided as a Source data file.
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models, we investigated the cell-autonomous responsiveness of
brown and beige adipocytes.
We found that the treatment of brown adipocytes with
bradykinin and recombinant HMWK protein significantly
repressed Ucp1 transcript expression (Fig. 9a, left). Moreover,
HMWK caused some reduction in the extent of brown adipocyte
differentiation, as evidenced by reduced appearance of multi-
locular lipid droplets in cells (Fig. 9a, right). We also found
repressive effects of bradykinin and HMWK on lipolysis (glycerol
release), which contrasted with the known inducing effects of
cAMP (Fig. 9b). Brown adipocytes differentiating from pre-
cursors derived from iBAT of B1B2R-KO mice showed a mild
increase in morphological differentiation compared to cells
derived from WT mice (Fig. 9c, right), as well as an impaired
capacity to down-regulate Ucp1 transcript in response to
bradykinin (Fig. 9c, left). Moreover, brown adipocytes from
B1B2R-KO mice expressed higher levels of UCP1 protein both
under basal and cAMP- and norepinephrine-induced conditions
relative to WT cells (Fig. 9d). These data support an inhibitory
role of kallikrein–kinin derived products, mediated by B1/B2
kinin receptors, in brown adipocytes.
The general adipogenic differentiation of precursor cells
obtained from iWAT of B1B2R-KO mice was mildly increased
relative to that of cells from WT mice, especially under beiging-
inducing treatment (rosiglitazone) (Fig. 9e). In precursors from
B1B2R-KO iWAT induced to beiging, the transcript levels of the
general adipogenic factor PPARγ and the adipogenic marker
FABP4 were significantly increased, and induction of Ucp1 and
Cidea transcripts was also observed (Fig. 9f). Accordingly, UCP1
protein levels were significantly upregulated in B1B2R-KO beige
cells (Fig. 9g).
We analyzed how iWAT precursor cells differentiated to a
preferential white phenotype (no rosiglitazone treatment, UCP1
expression around 10% of that in beige adipocytes) responded to
bradykinin; we found no repressive effects, but instead observed a
significant induction of UCP1 protein levels (Fig. 9h). In contrast,
when cells were driven to a beige phenotype (rosiglitazone
treatment), bradykinin treatment reduced UCP1 protein levels
(Figs. 9h and 9i), similarly to our previous observations in brown
adipocytes.
Collectively, these findings confirm that the kallikrein–kinin
system exerts repressive effects on the thermogenic activation of
brown and beige adipocytes, whereas no such effect (and even the
opposite effect) is seen in white adipocytes.
BK inhibits the p38–MAPK pathway of thermogenic activa-
tion. In order to ascertain the mechanisms through which bra-
dykinin exerts repressive effects on brown adipocyte thermogenic
activation, we first analyzed the potential involvement of Gq and/
or Gi-subtype G-protein-coupled receptors, which are potential
targets of bradykinin action in other cell systems23. Treatment of
brown adipocytes with a Gq inhibitor did not alter the repressive
action of bradykinin on Ucp1 or Cidea transcript levels, as bio-
markers of brown fat thermogenic activation. In contrast, Gi
inhibition suppressed the repressive effect of bradykinin on these
transcript levels (Fig. 10a, left). Consistent with the findings
shown previously, bradykinin did not repress thermogenesis-
related Ucp1 and Cidea transcript levels in white adipocytes,
instead tended to increase them; moreover the Gq and Gi inhi-
bitors did not have any relevant effects (Fig. 10a, right).
We then analyzed the effects of bradykinin on the activity of
PKA, which is a key driver of the regulation of thermogenic
activation in brown adipocytes24. Bradykinin did not alter the
basal levels of PKA activity but it blunted the ability of the β3-
adrenergic-activator CL316243 to induce PKA activity (Fig. 10b).
We also analyzed the potential involvement of p38 MAPkinase, a
main intracellular mechanism downstream of PKA that conveys





























































Fig. 7 Effects of CL316243 injection on iBAT temperature and O2 consumption. a Thermographic image of a WT and B1B2R-KO mouse 4min after
subcutaneous injection of CL316243 in the area of iBAT. b Time course of temperature increase in iBAT after CL316243 injection (n= 5 animals for PBS
and n= 6 animals for B1B2R-KO left graph; n= 5 animals for AUC). c Time course of O2 consumption after CL316243 injection (n= 3 animals for PBS and
n= 5 animals for B1B2R-KO both graphs). Data are presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01 versus corresponding controls; two-tailed
unpaired Student’s t-test. Source data are provided as a Source data file.
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bradykinin reduced the p38-MAPkinase phosphorylation level
and significantly impaired the induction of p38-MAPkinase
phosphorylation in response to CL316243 (Fig. 10c, left) in
brown adipocytes. These effects of bradykinin were suppressed in
B1B2R-KO mouse-derived brown adipocytes. Other intracellular
pathways potentially regulated by bradykinin in other cell
systems, such as NFκB26 (Fig. 10c, right), or Akt27 and Stat328
were unaffected (Supplementary Fig. 6). These data support the
idea that the PKA/p38 MAPK axis, which is the major
intracellular pathway of thermogenic activation of brown
adipocytes29, is subjected to bradykinin-receptor/Gi-mediated
repression.
Discussion
In the present study, we identified Kng as a factor released by
brown adipocytes in response to a thermogenic, noradrenergic-
mediated stimulus. Although the kallikrein–kinin system is a
poorly understood hormonal system, the limited available
research points to a role in inflammation, blood pressure control,
coagulation and pain8. To date, however, there has been no evi-
dence supporting a role for this system in brown adipose tissue-
related processes of adaptive energy expenditure. Here, we
demonstrate that the kallikrein–kinin system is involved in the
control of BAT activation and recruitment, and plays an inhibi-
tory role in the thermogenic function of brown fat (see scheme in
Fig. 10d).
We found that Kng2 is the Kng gene that is preferentially
expressed in BAT from mice. Expression of the Kng2 gene and
release of the encoded proteins is stimulated by a cAMP-medi-
ated, β3-adrenergic–induced regulatory mechanism, in concert
with the thermogenic activation of BAT and thermogenic-
induced browning of WAT.
A strong regulatory role for the kallikrein–kinin system in BAT
in the context of thermogenic stimuli is reinforced by the intense
reciprocal regulation between thermogenic activation and
expression of the kinin receptors B1 and B2, occurring at least at
transcript levels.
Despite our observation that a noradrenergic-mediated ther-
mogenic stimulus increased blood KNG2 levels in mice in concert
with induction of Kng2 expression specifically in BAT (and in the
browning-prone iWAT depot), our various experimental inter-
ventions in the kallikrein–kinin system point to major effects in
BAT itself rather than direct systemic effects. In rats defective for
KNG secretion, the most remarkable feature found was upregu-
lation of BAT activity; similarly, BAT overactivation was sys-
tematically observed in mice with pharmacological or genetic
disruption of the kinin receptor system. These results are in line
with our findings of inhibitory effects of Kng and bradykinin on
thermogenic activation of brown adipocytes. Therefore, our
findings identify a repressive action on thermogenic activity as
the major effect of kallikrein–kinin signals that act upon BAT.
The fact that a thermogenic stimulus (i.e., cold) results in the
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Fig. 8 Effects of temperature challenges on iWAT of B1B2R-KO mice. a H&E-stained histological sections and quantification (at least three different
pictures) of cell size and browning area in iWAT from 3 months old WT and B1B2R-KO mice exposed to 4 °C or 30 °C for 1 week. b Expression and
quantification of UCP1 and TH protein (n= 6 animals at 4 °C for UCP1 and TH except WT 4 °C UCP1 where n= 7; n= 5 at 30 °C all conditions). Data are
presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus corresponding controls; two-tailed unpaired Student’s t-test. Source data
are provided as a Source data file.
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suppressive effects on thermogenic activity may seem counter-
intuitive at first glance, but it is not unique to the kallikrein–kinin
system. Additional examples of such behavior include several
brown adipocyte secreted factors such as sLR11 (a soluble relative
of the low-density lipoprotein receptor)30, endothelin A31,
endocannabinoids32 and probably myostatin33. Along with these
molecules, Kng may play a role in an autocrine-based
homeostatic mechanism that prevents excessive wasting of energy
upon thermogenic activation, as previously proposed to explain
this type of effect30. Although relatively few studies relating the
kallikrein–kinin system with energy metabolism, it has been
reported that systemic pharmacological blockade of B1 reduces
adiposity and improves the metabolic profile in rats34,35. More-
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fat-diet-induced obesity and improves glucose tolerance12,13
through mechanisms that do not involve changes in food intake,
observations that are consistent with our demonstration of a
repressive role of the kallikrein–kinin system on BAT activity.
In most settings, we found parallel WAT browning and BAT
activation responses to kallikrein–kinin loss-of-function experi-
mental strategies. However, in two of our experimental models—
local effects of kinin receptor antagonists on WAT and response
to cold in B1B2R-KO mice—blocking bradykinin action led to
impaired browning in WAT. The reason for these apparently
discrepant observations is unclear. In our in vitro studies, we
found repressive effects due to bradykinin signaling in brown
adipocytes as well as in cells induced to differentiate into beige
adipocytes, but not in white adipocytes. We cannot rule out the
possibility that the induction of BAT activity elicited by kinin
receptor invalidation represses the extent of WAT browning
owing to reciprocal compensatory processes similar to those
reported in other mouse models36,37. However, our experimental
data in cell culture point to a potential cell-autonomous differ-
ential role of the kallikrein–kinin system on WAT and BAT.
It is worth mentioning that our in vivo experimental models
based on thermal challenges did not allow us to unequivocally
establish whether central effects of the kallikrein–kinin system38
are also involved in controlling of brown fat activity. Our
observation that upregulation of UCP1 in models of
kallikrein–kinin loss-of-function is accompanied by increased
tyrosine hydroxylase, indicative of enhanced sympathetic inner-
vation, suggest that experimental suppression of the
kallikrein–kinin system elicits a global remodeling of sympathetic
innervation of BAT. However, the enhanced activity of BAT in
mice devoid of kinin receptors after pharmacological stimulation
with a β3-adrenoceptor agonist indicates the intrinsically
enhanced thermogenic capacity of BAT when kinin signaling is
impaired does not rely on acute central signaling. Accordingly, we
found that bradykinin can repress the thermogenic machinery of
brown adipocytes in a cell-autonomous manner through its
action on bradykinin receptors. Bradykinin appears to interfere
with the β3-adrenergic induction of thermogenic activation in
brown adipocytes through mechanisms involving the Gi subtype
of G-protein-coupled receptors; this results in the inhibition of
protein kinase-A activity and p38-MAPkinase, which are the
main canonical intracellular actors that mediate the induction of
Ucp1 gene transcription induction and overall of thermogenic
activation29. Such a mechanism is reminiscent of some, but not
all, previous findings that have reported decreased cAMP levels in
response to the activation of kinin receptors in other non-adipose
cellular targets39. However, it has also been reported that acti-
vation of kinin receptors may either increase40 or fail to modify41
cAMP levels, depending on the cell type under study. Further
research is warranted to explore the molecular basis of this dis-
tinct cell-specific responsiveness to bradykinin.
In summary, we have identified a previously unsuspected
pathway for controlling BAT thermogenic activity mediated by
the kallikrein–kinin system, which is likely to act as an autocrine,
autoregulatory mechanism in response to a thermogenic stimu-
lus. This finding may contribute to expanding the range of
potential pharmacological candidates in therapeutic strategies
against obesity and associated diseases designed to improve
energy expenditure and remove excess blood metabolites through
activation of BAT.
Methods
Reagents, antibodies, and primers. All commercial kits, reagents, antibodies,
primers and TaqMan probes are listed in Supplementary Methods.
Animals. C57BL/6-Bdkrb2/Bdkrb1tm1Mki/J (B1B2R-KO) mice and their littermate
controls (WT) were purchased from Jackson Laboratory (Bar Harbor, ME, USA).
Swiss and C57BL/6J mice, as well as Brown Norway rats (BN/RijHsd colony), were
obtained from Harlan Laboratories (Indianapolis, IN, USA). BN/Ka breeder rats
were kindly provided by Drs. E. Kaschina and T.Unger (Charité University, Berlin,
Germany). Animals were housed at 22 °C under a 12-h light cycle (lights on, 08.00
am to 08.00 pm) with 50% ±5% relative humidity with free access to water and a
standard diet.
For cold-exposure experiments, 12 weeks old B1B2R-KO, C57BL/6J, or WT
Swiss male animals and their corresponding controls were exposed to a
temperature of 4 °C for 1 week. For thermoneutrality experiments, 12 weeks old
B1B2R-KO male animals and their controls were exposed to 30 °C for 1 week using
a thermostatic chamber (TDI Euro Aire). Male, WT Brown Norway and BN/Ka
rats (12 weeks old) were kept at thermoneutrality (27 °C) for 22 days or exposed to
cold (4 °C) for 24 hours or 22 days. Where indicated, 9-weeks old C57BL/6J male
mice were anesthetized with 1.5% isoflurane and subcutaneously implanted in their
interscapular or inguinal region with an osmotic mini-pump. Mini-pumps,
calibrated to release their content at a rate of 0.5 µl/h for 7 days, were filled with
phosphate-buffered saline (PBS) or a cocktail of B1 (R715) and B2 (HOE 140)
receptor antagonists at a concentration designed to deliver the respective agents at
a rate of 700 and 400 µg/kg/d. Animals and food were weighed daily during
temperature-challenge treatments. Where indicated, mice were injected
subcutaneously into the interscapular region over the BAT depot with 1 mg/kg
CL316243, and their surface temperature was monitored every minute for 10 min
with a T335 infrared digital thermography camera (FLIR Systems)42–44. The same
camera was used for obtaining thermographic images of rats; images were analyzed
using the FLIR QuickReport software (FLIR Systems). Oxygen consumption was
Fig. 9 Effects of Kng and bradykinin on brown, white and beige adipocytes in culture. a Ucp1 mRNA expression in differentiated primary brown
adipocytes incubated for 10 h with cAMP, bradykinin or recombinant HMWK protein (n= 9 independent cell culture experiments); representative
microscopy pictures of controls (CTL) and HMWK-treated (24 h) primary brown adipocytes after 11 days of differentiation, with quantification of
multilocular lipid droplets area (at least three different pictures). b Glycerol levels in culture media from brown adipocytes treated with cAMP, bradykinin
or HMWK for 24 h (n= 9 independent cell culture experiments for all conditions except BK where n= 3). c Ucp1 mRNA expression in differentiated
primary brown adipocytes from WT or B1B2R-KO mice treated 24 h to bradykinin (n= 6 independent cell culture experiments for WT; n= 3 for B1B2R-KO
CTL and n= 4 for B1B2R-KO BK); Images of WT and B1B2R-KO primary brown adipocytes after 11 days of differentiation, with quantification of multilocular
lipid droplets area (at least three different pictures). d UCP1 protein levels in WT and B1B2R-KO primary brown adipocytes treated 24 h to different cAMP
or norepinephrine (NE) (n= 3 independent cell culture experiments). Representative images (same immunoblot membrane, same exposure setting) of
UCP1 immunoblots (top) and quantification of UCP1 levels (bottom). e Representative microscopy images of WT and B1B2R-KO primary white adipocytes
after 8 days of differentiation in the presence or absence of the browning stimulator rosiglitazone (rosi), with quantification of multilocular lipid droplets
area (at least three different pictures). f Fold-induction of mRNA for genes involved in thermogenesis and adipogenesis in primary white adipocytes (n= 3
independent cell culture experiments for all genes except for Pgc1a where n= 4 and Pparg where n= 5). g Expression and quantification of UCP1 protein in
WT and B1B2R-KO primary white adipocytes (n= 3 independent cell culture experiments). h UCP1 protein expression and quantification of primary white
(−rosi) and beige (+rosi) adipocytes after 24 h of bradykinin exposition (n= 3 independent cell culture experiments). i Expression of UCP1 mRNA and
protein in primary beige adipocytes differentiated in presence of rosiglitazone after stimulation with different concentrations of bradykinin for 24 h (n= 3
independent cell culture experiments). Data are presented as means ± s.e.m. (bars). *P < 0.05, **P < 0.01, and ***P < 0.001 versus corresponding controls;
P-values determined by one way ANOVA with Tukey’s post hoc test (a left, b, c left, d, e, i) and two-tailed unpaired Student’s t-test (a right, c right, f, g, h).
Source data are provided as a Source data file.
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Fig. 10 Regulation of thermogenic pathways by the kallikrein–kinin system. a mRNA expression of genes involved in thermogenesis and adipogenesis in
primary brown (n= 6 independent cell culture experiments, except for Gq/BK condition where n= 4) and white adipocytes (n= 3 independent cell culture
experiments) exposed to Gq/i inhibitors in presence or absence of bradykinin for 24 h. b Protein kinase A activity in primary brown adipocytes exposed to
bradykinin, CL316243 or both for 15 min. Representative picture of electrophoresis assay of phosphorylated and non-phosphorylated PKA substrate and
quantification (n= 3 independent cell culture experiments). c Phosphorylation status of p38MAPK (n= 3 independent cell culture experiments, except for
WT BK where n= 5 and B1B2R-KO BK and BK/CL where n= 4 and n= 6, respectively) and p65 NFκB (n= 3 independent cell culture experiments, except
for WT and B1B2R-KO BK and BK/CL where n= 6) in primary WT and B1B2R-KO brown adipocytes exposed to CL316243, bradykinin or both for 15min,
normalized with total p38MAPK and p65 NFκB. d Schematic representation of the effects of the kallikrein–kinin system in brown/beige adipocytes. Data
are presented as means ± s.e.m. (bars). *P < 0.05 and **P < 0.01 versus corresponding controls; P-values determined by one way ANOVA with Tukey’s
post hoc test (c) and two-tailed unpaired Student’s t-test (a, b). Source data are provided as a Source data file.
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measured in mice housed individually in Labmaster metabolic cages (TSE, Bad
Homburg, Germany) after 2 days of adaptation45.
All experiments were performed in accordance with European Community
Council directive 86/609/EEC, and experimental protocols as well as the number of
animals, determined based on the expected effects size, were approved by the
Institutional Animal Care and Use Committee at the University of Barcelona. After
being anesthetized, 2–5 months old mice and rats were sacrificed by rapid
decapitation, and blood/tissues were collected and stored at −80 °C.
Cell culture. Stromal vascular cells were obtained from iBAT dissected from 3-
weeks old Swiss mice (mix of males and females). Differentiation was induced by
exposing confluent precursor cells in DMEM/F12 medium containing 10% foetal
bovine serum and supplemented with 20 nM insulin, 2 nM T3 and 0.1 mM
ascorbic acid. Experiments were performed on day 10 of culture, when more than
90% of cells were differentiated, or on days 4, 6, and 8 during differentiation, as
indicated. For culture of primary white adipocytes, stromal vascular cells were
obtained from iWAT of 5-week old WT or B1B2R-KO mice, and induced to
differentiate into adipocytes by maintaining confluent precursors in DMEM/F12
containing 10% newborn calf serum, supplemented with 850 nM insulin, 3 μM T3
and 35 nM dexamethasone. Beiging was induced by adding rosiglitazone (10 µM)
to the cell media during differentiation at the time cells had reached confluence.
Experiments were performed on day 8 of culture, when more than 90% of cells
were differentiated. Where indicated, cells were exposed to cAMP (1 mM), nor-
epinephrine (0.5 µM), CL316243 (1 µM), bradykinin (1 µM), HMWK (10 nM), Gq
inhibitor YM254890 (10 µM) or Gi inhibitor (pertussis toxin) (100 ng/ml) at the
indicated timing (24 h or 15 min) on day 10 (brown adipocytes) or day 8 (beige
adipocytes) of in vitro differentiation. In the case of Gq/i experiment, inhibitors
were added 30 min before bradykinin. Microscopy images were obtained, multi-
locular lipid droplets areas were quantified using Image J 2.0 and cells were col-
lected for RNA and protein extraction.
Circulating parameters. Triglyceride and glucose levels were measured in blood
using an Accutrend Technology system (Roche Diagnostics, Basel, Switzerland).
Insulin, leptin, and cytokines were measured in plasma using a Multiplex system
(MADKMAG-HK, Millipore). All measurements have been performed on fed
animals.
Glycerol was measured in cell culture media, using spectrophotometric
methodology.
Histological analysis. Tissues were fixed overnight in 4% paraformaldehyde,
sectioned (5-μm thick), and stained with hematoxylin and eosin (H&E) for further
morphological investigation. The surface area of lipid droplets and the percentage
of browning in adipose tissue areas were quantified with Image J 2.0 (NIH) and
Adiposoft extension.
Immunofluorescence. For immunofluorescence, rehydrated tissue sections were
blocked by incubating with 3% bovine serum albumen (BSA) for 1 h at room
temperature. Preparations were then incubated with rabbit anti-UCP1 antibody at
a dilution of 1/100, followed by incubation with AlexaFluor 488-conjugated anti-
rabbit secondary antibody at a dilution of 1/1500. Immunofluorescence signals
were visualized under a fluorescence microscope (Leica) and quantified using
Image J 2.0.
Real-time PCR. Total RNA was extracted using a Nucleospin RNA column kit and
reverse transcribed using a high capacity cDNA kit. Samples were systematically
checked for no-amplification in the absence of reverse transcriptase. Quantitative
real-time PCR was performed using a TaqMan system; in cases where TaqMan
probes were not available, SYBR Green was employed in conjunction with a Ste-
pOne PCR system (Life Technologies, Carlsbad, CA, USA). Primer sequences for
SYBR Green-based PCR and assay probes for TaqMan are listed in Supplementary
Methods. cDNA levels for the gene of interest were normalized to that of the
reference control using the comparative CT(2−ΔΔCT) method, according to the
manufacturer’s instructions. A transcript was considered to be not-detectable for
CT values ≥40.
Western blot and milliplex analysis. Homogenized tissues or cells were lysed in
ice-cold RIPA buffer. Equal amounts of protein were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12% gradient gels and
blotted onto PVDF (polyvinylidenedifluoride) membranes. Proteins were probed
with specific primary antibodies (dilution 1/1000) and HRP-conjugated secondary
antibodies (dilution 1/3000) in conjunction with chemiluminescence detection.
Loading controls were established using Ponceau or Coomassie staining. Quanti-
fication was performed using Multi Gauge V3.0 Software (Fujifilm, Tokyo, Japan).
For milliplex multipathway analysis of total and phosphorylated proteins, cells
were lysated and processed according to the manufacturer instructions
(MADKMAG-HK, Millipore). The reading was done using a Luminex system.
PKA activity. PKA enzymatic activity was measured using the PepTag® Non-
Radioactive Protein Kinase Assay kit. Cells were exposed to bradykinin, CL316243,
or both, at the indicated concentrations for 15 min. Enzyme activity was estimated
through separation of the non-phosphorylated versus phosphorylated PKA sub-
strate on a 0.8% agarose gel, followed by densitometric measurement of signal
intensity, and calculation of the phosphorylated/non-phosphorylated ratios,
according to the manufacturer instructions.
Statistical analysis. Results are expressed as means ± SEM of at least three
independent experiments or at least four different animals per group. Results were
analyzed by Student’s t-test or one-way analysis of variance (ANOVA) followed by
a Tukey’s multiple-comparisons test, in cases where more than two group groups
or multiple time points, using GraphPad statistical software (GraphPad Software
Inc., San Diego, CA, USA). P-values < 0.05 were considered significant; individual
P-values are shown in figure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq performed for Quesada-Lopez et al. study46 was used here. The raw data are
accessible in Gene Expression Omnibus (GEO) using accession number GSE77534. The
complete list of cold-modulated genes in BAT revealed by analysis of RNA-seq data is
available at [http://lmedex.ulb.ac.be/data.php]. Source data underlying this study is
available as a Source Data file, or from the corresponding author upon reasonable
request.
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